Is The Chemours Co. overvalued or undervalued?

As of 18 February 2025, The Chemours Co. has moved from an expensive valuation grade to very attractive. The company is currently undervalued, with a P/E ratio of 12, which is significantly lower than the industry average. Notably, the PEG ratio stands at an impressive 0.06, indicating strong growth potential relative to its price, while the EV to EBITDA ratio is 7.55, suggesting that the company is trading at a reasonable multiple compared to its earnings before interest, taxes, depreciation, and amortization.
In terms of peer comparison, The Chemours Co. has a P/E of 11.48 and an EV to EBITDA of 7.46, which are both favorable compared to its peers. The company's dividend yield is exceptionally high at 377.74%, which further enhances its attractiveness to investors. Despite recent stock performance lagging behind the S&P 500, with a year-to-date return of -37.28% compared to the S&P's 2.44%, the underlying financial metrics suggest that The Chemours Co. is positioned for potential recovery and growth, reinforcing its undervalued status.